NCT00209508View on ClinicalTrials.gov

2 Year Study to Evaluate the Effects of GPI 1485 on [123I]b-CIT/SPECTScanning and Clinical Efficacy in Patients With PD

PHASE2CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

November 30, 2002

Study Completion Date

October 31, 2005

Conditions

Parkinson's Disease

Interventions

DRUG

GPI 1485

All Listed Sponsors

collaborator

Symphony Neuro Development Company

INDUSTRY

lead

Eisai Inc.

INDUSTRY

NCT00209508 - 2 Year Study to Evaluate the Effects of GPI 1485 on [123I]b-CIT/SPECTScanning and Clinical Efficacy in Patients With PD | Biotech Hunter | Biotech Hunter